Chile´s Tribunal for the Defense of Free Competition (TDLC) picked up this Friday November 9 the request for probing a possible case of collusion filed by the National Economic Prosecutor’s Office (FNE) against Biosano laboratories, Fresenius Kabi Chile and its subsidiary Sanderson, for allegedly forming a cartel affecting bids called by the Supply Center for the National System of Health Services (Cenabast).
The TDLC imposed on Sanderson and Fresenius an obligation to adopt a free competition compliance program for five years in accordance with the “Guide to Compliance Programs of Free Competition Regulations”, prepared by the FNE. This is added to the fines for 30 thousand Annual Tax Units (UTA, equivalent to US$25.6 million) to Laboratorios Sanderson and 2,463 UTA, equivalent to US $2.1 million, to Fresenius Kabi Chile, while Biosano escaped fines by joining the agency´s leniency program.
In its ruling, the TDLC noted that “the evidence cited above shows that the accused had agreed to affect bidding processes convened by Cenabast for the provision of ampoules, from at least 1999 to February 2013.” This is the sixth time that the FNE publicly presents the TDLC with a case that incorporates the leniency compensation mechanism, available in Chile since 2009.
Featured News
FTC Targets Oil Executive John Hess Over Alleged Collusion with OPEC
Sep 30, 2024 by
CPI
Chevron Clears Major Hurdle in Hess Merger as FTC Approves Antitrust Review
Sep 30, 2024 by
CPI
Germany Targets Microsoft in Latest Antitrust Action Against Big Tech
Sep 30, 2024 by
CPI
Judge Dismisses Antitrust Claims Against Thomson Reuters in Legal Search Battle
Sep 30, 2024 by
CPI
Epic Games Files Fresh Antitrust Lawsuit Targeting Google and Samsung
Sep 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh